Boost Study 31380 (mHealth)
BoostOne Study (MHealth)
2 other identifiers
interventional
43
1 country
1
Brief Summary
The purpose of this research is to examine the potential for a new software-based behavioral support approach, for individuals with opioid use disorder, as an addition to usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 18, 2022
CompletedFirst Submitted
Initial submission to the registry
January 31, 2023
CompletedFirst Posted
Study publicly available on registry
March 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedResults Posted
Study results publicly available
December 18, 2024
CompletedDecember 18, 2024
December 1, 2024
12 months
January 31, 2023
May 9, 2024
December 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Interaction Engagement, as Assessed by Interactions Completed
Interactions Completed (interactions completed, range 0 to unbound)
At 8 weeks
Secondary Outcomes (2)
Intervention Usability Rating, as Assessed by Likert User Experience Scale
At 8 weeks
Treatment Progress Measure, as Assessed by TEA Score
At 8 weeks
Study Arms (1)
Experimental
EXPERIMENTALmHealth group
Interventions
Eligibility Criteria
You may qualify if:
- Age 18-65 years
- Diagnosis of opioid use disorder
- Experiencing symptoms multiple times per week
- Familiar with smartphone usage
You may not qualify if:
- \- None specified
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NXTechlead
- National Institutes of Health (NIH)collaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
PHNY
Astoria, New York, 11106, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Principal Investigator for Study 31380
- Organization
- NXTech
Study Officials
- PRINCIPAL INVESTIGATOR
Alexis Vien, MD
PHNY
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2023
First Posted
March 7, 2023
Study Start
April 18, 2022
Primary Completion
March 30, 2023
Study Completion
March 30, 2023
Last Updated
December 18, 2024
Results First Posted
December 18, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share